ReviewPharmaceutics2021

Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles.

Fen Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.